Description

Myo-Inositol, 2,4,5-Tris-o-(Phenylmethyl)-1,6-o-(1,7,7-Trimethylbicyclo2.2.1Hept-2-Ylidene)- CAS NO 196306-65-7 is a sophisticated, multi-protected derivative of myo-inositol, a key biochemical precursor. This compound is specifically engineered to provide controlled reactivity and selectivity in advanced synthetic pathways, making it a critical intermediate for high-value chemical synthesis. It is primarily utilized by research institutions and pharmaceutical companies engaged in the development of complex bioactive molecules, signaling pathway modulators, and specialized chiral building blocks.

Application

• Pharmaceutical Intermediate: Serves as a key chiral synthon in the research and development of novel drug candidates, particularly those targeting cellular signaling pathways.
• Biochemical Research: Used as a protected precursor in studies involving inositol phosphate metabolism and the synthesis of phosphoinositide analogs.
• Organic Synthesis: Acts as a versatile, multi-functional intermediate for constructing complex polycyclic or carbohydrate-derived molecular architectures.
• Chemical Biology Probes: Employed in the creation of labeled or modified inositol derivatives for probing enzyme mechanisms and biological interactions.
• Asymmetric Catalysis Substrate: Utilized in the development and testing of new catalytic methodologies due to its multiple stereocenters and protective groups.

Basic Information

Product Name	Myo-Inositol, 2,4,5-Tris-o-(Phenylmethyl)-1,6-o-(1,7,7-Trimethylbicyclo2.2.1Hept-2-Ylidene)-
CAS No.	196306-65-7
Molecular Formula	C41H48O6
Molecular Weight	636.82 g/mol
Synonyms	1,6-O-(1,7,7-Trimethylbicyclo[2.2.1]hept-2-ylidene)-2,4,5-tris-O-(phenylmethyl)-myo-inositol; 2,4,5-Tri-O-benzyl-1,6-O-(1,7,7-trimethylbicyclo[2.2.1]hept-2-ylidene)-myo-inositol; myo-Inositol, 2,4,5-tris-O-(phenylmethyl)-1,6-O-(1,7,7-trimethylbicyclo[2.2.1]hept-2-ylidene)-; 2,4,5-Tri-O-benzyl-1,6-O-(2-bornylidene)-myo-inositol; 1,6-O-(2-Bornylidene)-2,4,5-tri-O-benzyl-myo-inositol; Protected myo-inositol derivative; Benzyl-protected inositol acetonide analog.
EINECS	Contact for details

Quality Control

Our products undergo rigorous quality testing to ensure compliance with industry standards for research and pharmaceutical intermediates. Each batch is characterized using advanced analytical techniques including HPLC, NMR, and mass spectrometry to confirm identity and purity. Certificates of Analysis (COA) detailing all relevant specifications are available upon request, supporting your quality assurance and regulatory documentation needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (typically 15-25°C). This compound should be handled in accordance with good laboratory practices to maintain its stability and purity.

Specification

Item	Specification
Appearance	White to off-white powder or crystalline solid
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 95.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.